Ruxolitinib in COVID-19 patients with defined hyperinflammation: the RuxCoFlam trial

被引：0
作者：
Birndt, S. [1 ]
Hammersen, J. [1 ]
Doehner, K. [2 ]
Reuken, P. [3 ]
Sauerbrey, P. [1 ]
La Rosee, F. [4 ]
Pfirrmann, M. [5 ]
Fabisch, C. [1 ]
Weiss, M. [6 ]
Traeger, K. [6 ]
Bremer, H. [7 ]
Illerhaus, G. [8 ]
Droemann, D. [9 ]
Schneider, S. [10 ]
La Rosee, P. [11 ]
Hochhaus, A. [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med Hamatol & Internist Onkol 2, Jena, Germany
[2] Univ Klinikum Ulm, Klin Innere Med 3, Ulm, Germany
[3] Univ Klinikum Jena, Klin Innere Med 4, Interdisziplinare Endoskopie, Hepatol,Infektiol,Gastroenterol, Jena, Germany
[4] Univ Klinikum Dresden, Med Fak, Dresden, Germany
[5] LMU Munchen, Inst Med Informat Verarbeitung Biometrie & Epidem, Med Fak, Munich, Germany
[6] Univ Klinikum Ulm, Klin Anasthesiol & Intens Med, Ulm, Germany
[7] Schwarzwald Baar Klinikum, Lungenzentrum Donaueschingen, Donaueschingen, Germany
[8] Klinikum Stuttgart, Klin Hamatol Onkol Stammzellentransplantat & Pall, Stuttgart, Germany
[9] Univ Klinikum Schleswig Holstein, Med Klin Pulmol 3, Campus Lubeck, Lubeck, Germany
[10] SRH Klinikum Gera, Gera, Germany
[11] Schwarzwald Baar Klinikum, Klin Innere Med Hamatol Onkol Immunol Infektiol &, Villingen Schwenningen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V497
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [31] MITOCHONDRIAL DYSFUNCTION AND HYPERINFLAMMATION IN PEDIATRIC COVID-19 INFECTION
    Kim, Daniel
    Rakes, Lauren
    Mcguire, John
    CRITICAL CARE MEDICINE, 2024, 52
  • [32] Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
    Tanner, Tamara
    Wahezi, Dawn M.
    PAEDIATRIC RESPIRATORY REVIEWS, 2020, 35 : 81 - 87
  • [33] Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
    Zaid, Younes
    Dore, Etienne
    Dubuc, Isabelle
    Archambault, Anne-Sophie
    Flamand, Olivier
    Laviolette, Michel
    Flamand, Nicolas
    Boilard, Eric
    Flamand, Louis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (02) : 368 - +
  • [34] Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?
    Buemann, Benjamin
    Marazziti, Donatella
    Uvnas-Moberg, Kerstin
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2021, 22 (05) : 387 - 398
  • [35] The role of ibrutinib in COVID-19 hyperinflammation: A case report
    Maynard, Suzanne
    Ros-Soto, Jose
    Chaidos, Aris
    Innes, Andrew
    Paleja, Krushika
    Mirvis, Eitan
    Buti, Noora
    Sharp, Harriet
    Palanicawandar, Renuka
    Milojkovic, Dragana
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 274 - 276
  • [36] New Insights on COVID-19's Hyperinflammation in Children
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (15): : 1489 - 1489
  • [37] Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients?
    Mitamura, Y.
    Schulz, D.
    Akdis, C.
    Brueggen, M. -C.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 25 - 26
  • [38] Response to: Ruxolitinib withdrawal due to the COVID-19
    Barbui, Tiziano
    Carobbio, Alessandra
    LEUKEMIA, 2021, 35 (04) : 1219 - 1219
  • [39] Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients?
    Mitamura, Y.
    Schulz, D.
    Schmid-Grendelmeier, P.
    Lang, C.
    Bodenmiller, B.
    Steiger, P.
    Kolm, I.
    Maverakis, E.
    Akdis, C.
    Bruggen, M. C.
    SWISS MEDICAL WEEKLY, 2021, 151 : 2S - 2S
  • [40] Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients?
    Mitamura, Y.
    Schulz, D.
    Kolm, I.
    Oro, S.
    Levesque, M.
    Maverakis, E.
    Akdis, C.
    Bruggen, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S2 - S2
12345